Pharmagreen Biotech IncOTC Pink - Current Information:PHBI
- LAST PRICE0.0021
- TODAY'S CHANGE (%)-0.0004 (-16.0000%)
- Bid / Lots0.0019/ 100
- Ask / Lots0.0025/ 100
- Open / Previous Close0.0022 / 0.0025
- Day Range
- 52 Week Range
- Volume586,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PHBI |
|---|---|---|
| 09:32 ET | 100 | 0.0022 |
| 09:37 ET | 20000 | 0.0022 |
| 09:42 ET | 100000 | 0.002175 |
| 09:51 ET | 97500 | 0.0021 |
| 09:57 ET | 110000 | 0.0021 |
| 10:00 ET | 5000 | 0.0021 |
| 10:06 ET | 3000 | 0.0021 |
| 10:09 ET | 2000 | 0.0022 |
| 10:31 ET | 20389 | 0.002 |
| 10:38 ET | 20961 | 0.002 |
| 10:42 ET | 10000 | 0.002 |
| 11:12 ET | 55000 | 0.00195 |
| 11:30 ET | 2000 | 0.00195 |
| 11:32 ET | 21000 | 0.0021 |
| 11:41 ET | 1000 | 0.0022 |
| 01:09 ET | 81000 | 0.002 |
| 01:36 ET | 1000 | 0.0021 |
| 01:40 ET | 1000 | 0.0022 |
| 02:07 ET | 2000 | 0.0021 |
| 03:50 ET | 3050 | 0.002 |
| 04:00 ET | 30000 | 0.0021 |
Oct 10, 2024
Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project, from 9:15AM ET on Thursday Oct 10, 2024 by Dow Jones
9:15AM ET on Thursday Oct 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pharmagreen Biotech Inc | 1.7M | -3.0x | --- |
Kiromic Biopharma Inc | 1.7M | -0.1x | --- |
Panbela Therapeutics Inc | 1.8M | 0.0x | --- |
Dermata Therapeutics Inc | 1.8M | -0.1x | --- |
Zyversa Therapeutics Inc | 1.9M | 0.0x | --- |
CohBar Inc | 1.4M | -0.1x | --- |
Company Information
Pharmagreen Biotech, Inc. is a Canada-based company. The Company is engaged in developing its line of nutraceutical products, which is a blend of therapeutic plants and mushrooms. Utilizing the Company's expertise in plant genetics, its transgenic program uses the technology available to research and create nutraceuticals, and daily supplements with the potential to improve lives and address a wide variety of ailing conditions. Its nutraceutical product, MaxGenomic Supplement, comes in a bottle with 60 enteric capsules. The MaxGenomic Supplement is a proprietary blend that consists of nine medicinal mushrooms and six medical plants to help support the human mind and body. Its other nutraceutical products are in various development stages. Its subsidiaries include WFS Pharmagreen Inc, and 1155097 BC Ltd.
Contact Information
- Headquarters
- 2987 Blackbear CrtCOQUITLAM, BC, Canada V3E 3A2
- Phone
- 404-671-9253
- Fax
- ---
Executives
- President, Director; Chief Executive Officer, Director of WFS Pharmagreen Inc.
- Peter Wojcik
- Chief Financial Officer, Director of WFS Pharmagreen Inc.
- Terry Kwan
- Chief Operating Officer of WFS Pharmagreen Inc.
- Fawzia Afreen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7M |
|---|---|
Revenue (TTM) | $4.4K |
Shares Outstanding | 663.6M |
Pharmagreen Biotech Inc does not pay a dividend. | |
Beta | 2.02 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | 380.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,227.29% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
